Venetoclax plus hypomethylating agents as first salvage therapy for myeloid malignancies relapsing after allogeneic HSCT.
Saved in:
| Title: | Venetoclax plus hypomethylating agents as first salvage therapy for myeloid malignancies relapsing after allogeneic HSCT. |
|---|---|
| Authors: | Chiusolo P; Section of Hematology, Department of Laboratory and Hematological Sciences, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy., Malagola M; University of Brescia, Adult Bone Marrow Transplant Unit, ASST Spedali Civili di Brescia, Brescia, Italy., Giglio F; IEO, Clinical Haemato-Oncology Division Via Ripamonti, Milano, Italy., Frioni F; Section of Hematology, Department of Laboratory and Hematological Sciences, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy., Secreto C; Division of Haematology, Department of Oncology, A.O.U. Città Della Salute e della Scienza di Torino, Turin, Italy., Lessi F; Ematologia Azienda Ospedale Padova, Padova, Italy., D'Amore F; Ematologia Azienda Ospedale Padova, Padova, Italy., Monella IM; IEO, Clinical Haemato-Oncology Division Via Ripamonti, Milano, Italy., Abbenante M; Ospedale Opera Padre Pio-San Giovanni Rotondo, San Giovanni Rotondo, Italy., Marconi G; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy., Nanni J; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy., Maggi R; Section of Hematology, Department of Laboratory and Hematological Sciences, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy., Mattozzi A; Section of Hematology, Department of Laboratory and Hematological Sciences, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy., Giammarco S; Section of Hematology, Department of Laboratory and Hematological Sciences, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy., Busca A; Division of Haematology, Department of Oncology, A.O.U. Città Della Salute e della Scienza di Torino, Turin, Italy., Sica S; Section of Hematology, Department of Laboratory and Hematological Sciences, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy. simona.sica@unicatt.it., Papayannidis C; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy. |
| Source: | Bone marrow transplantation [Bone Marrow Transplant] 2026 Jan; Vol. 61 (1), pp. 101-103. Date of Electronic Publication: 2025 Oct 21. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41120716 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Venetoclax plus hypomethylating agents as first salvage therapy for myeloid malignancies relapsing after allogeneic HSCT. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Chiusolo+P%22">Chiusolo P</searchLink>; Section of Hematology, Department of Laboratory and Hematological Sciences, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Malagola+M%22">Malagola M</searchLink>; University of Brescia, Adult Bone Marrow Transplant Unit, ASST Spedali Civili di Brescia, Brescia, Italy.<br /><searchLink fieldCode="AU" term="%22Giglio+F%22">Giglio F</searchLink>; IEO, Clinical Haemato-Oncology Division Via Ripamonti, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Frioni+F%22">Frioni F</searchLink>; Section of Hematology, Department of Laboratory and Hematological Sciences, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Secreto+C%22">Secreto C</searchLink>; Division of Haematology, Department of Oncology, A.O.U. Città Della Salute e della Scienza di Torino, Turin, Italy.<br /><searchLink fieldCode="AU" term="%22Lessi+F%22">Lessi F</searchLink>; Ematologia Azienda Ospedale Padova, Padova, Italy.<br /><searchLink fieldCode="AU" term="%22D'Amore+F%22">D'Amore F</searchLink>; Ematologia Azienda Ospedale Padova, Padova, Italy.<br /><searchLink fieldCode="AU" term="%22Monella+IM%22">Monella IM</searchLink>; IEO, Clinical Haemato-Oncology Division Via Ripamonti, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Abbenante+M%22">Abbenante M</searchLink>; Ospedale Opera Padre Pio-San Giovanni Rotondo, San Giovanni Rotondo, Italy.<br /><searchLink fieldCode="AU" term="%22Marconi+G%22">Marconi G</searchLink>; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Nanni+J%22">Nanni J</searchLink>; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Maggi+R%22">Maggi R</searchLink>; Section of Hematology, Department of Laboratory and Hematological Sciences, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Mattozzi+A%22">Mattozzi A</searchLink>; Section of Hematology, Department of Laboratory and Hematological Sciences, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Giammarco+S%22">Giammarco S</searchLink>; Section of Hematology, Department of Laboratory and Hematological Sciences, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Busca+A%22">Busca A</searchLink>; Division of Haematology, Department of Oncology, A.O.U. Città Della Salute e della Scienza di Torino, Turin, Italy.<br /><searchLink fieldCode="AU" term="%22Sica+S%22">Sica S</searchLink>; Section of Hematology, Department of Laboratory and Hematological Sciences, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy. simona.sica@unicatt.it.<br /><searchLink fieldCode="AU" term="%22Papayannidis+C%22">Papayannidis C</searchLink>; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228702459%22">Bone marrow transplantation</searchLink> [Bone Marrow Transplant] 2026 Jan; Vol. 61 (1), pp. 101-103. <i>Date of Electronic Publication: </i>2025 Oct 21. – Name: TypePub Label: Publication Type Group: TypPub Data: Letter – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8702459 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5365 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202683369%22">02683369 </searchLink><i>NLM ISO Abbreviation: </i>Bone Marrow Transplant <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41120716 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41409-025-02723-x Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 101 Titles: – TitleFull: Venetoclax plus hypomethylating agents as first salvage therapy for myeloid malignancies relapsing after allogeneic HSCT. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Chiusolo P – PersonEntity: Name: NameFull: Malagola M – PersonEntity: Name: NameFull: Giglio F – PersonEntity: Name: NameFull: Frioni F – PersonEntity: Name: NameFull: Secreto C – PersonEntity: Name: NameFull: Lessi F – PersonEntity: Name: NameFull: D'Amore F – PersonEntity: Name: NameFull: Monella IM – PersonEntity: Name: NameFull: Abbenante M – PersonEntity: Name: NameFull: Marconi G – PersonEntity: Name: NameFull: Nanni J – PersonEntity: Name: NameFull: Maggi R – PersonEntity: Name: NameFull: Mattozzi A – PersonEntity: Name: NameFull: Giammarco S – PersonEntity: Name: NameFull: Busca A – PersonEntity: Name: NameFull: Sica S – PersonEntity: Name: NameFull: Papayannidis C IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2026 Jan Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1476-5365 Numbering: – Type: volume Value: 61 – Type: issue Value: 1 Titles: – TitleFull: Bone marrow transplantation Type: main |
| ResultId | 1 |